The latest market report published by Credence Research, Ltd. “Autoimmune Diseases Treatment Market – Growth, Share, Opportunities, Pipeline Analysis, Competitive Analysis, and Forecast, 2016 – 2022,” the autoimmune diseases treatment market was valued at USD 40,944.9 Mn in 2015, and is expected to reach USD 52,456.3 Mn by 2022, expanding at a CAGR of 3.53% from 2016 to 2022.
The purpose of the report is to illustrate the state of the market of Sterile Injectables, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2026.
Browse here for full report: https://www.credenceresearch.com/report/autoimmune-diseases-treatment-market
According to American Autoimmune Related Diseases Association (AARDA), autoimmune diseases are caused by functional turbulence caused to immune system. Autoimmune reactions occur when the immune system produces autoantibodies that attack and destroy healthy tissues in the body rather than infectious agents. These autoantibodies cause inflammation, pain, and organ damage. Autoimmune disease is one of the top 10 leading causes of death in girls and women in all age groups up to 64 years of age. A close genetic relationship exists among autoimmune disease, explaining clustering in individuals and families as well as a common pathway of disease. The currently available treatment comprises chemical-based drugs such as immunosuppressant, corticosteroids and NSAIDs. Biological drugs are considered as the most developing segment of autoimmune diseases treatment market due to target-specific activity, less side-effects and high patient compliance compared to chemical- based drugs. The key factors assisting the growth of autoimmune diseases treatment market are growing prevalence of autoimmune diseases coupled with growing public awareness, rising healthcare expenditure in the developed and developing regions and developing technology of laboratories leading to diagnosis of several autoimmune diseases swiftly. On the other hand, insufficient funding in emerging countries and high cost involved in the treatment of the disease are hindering the market growth of autoimmune diseases treatment.
Pipeline of autoimmune diseases is dense and comprises of combination of chemical-based and biological drugs. However, the no. of biological molecules is more in the phase III of clinical trials compared to chemical-based drugs. There are more than 80 types of clinically different autoimmune diseases. Some of the common types of autoimmune diseases are Hashimoto’s thyroiditis, type I diabetes, Crohn’s disease, multiple sclerosis, rheumatoid arthritis, ankylosing spondylitis systemic lupus erythematosus, and psoriasis. We have estimated sales of very specific molecules based on the type (chemical-based or biological), disease prevalence, sponsor, depicted peak sales by leading market experts and other factors.
Why was the report written?
This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Sterile Injectables buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.
What is the current market landscape and what is changing?
Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.
The report on the market of Autoimmune Diseases Treatment contains:
Analysis and forecast of Sterile Injectables market dynamics;
Analysis of domestic production, market shares of the main market players;
Analysis of exports and imports;
Analysis of factors, leading the development of the Sterile Injectables market;
Assessment and forecast of Sterile Injectables market development;
Financial and business profiles of the leading companies in the Sterile Injectables industry.
– Up to date working Sterile Injectables data by major regions in the world, the forecast of planned capacity additions by 2026
– The annual breakdown of capital expenditure spending on proposed Sterile Injectables for the period 2018 to 2026
– Planned Sterile Injectables additions and capital expenditure spending by key countries and companies across the world
– Planned capital expenditure spending on new Sterile Injectables projects by region, key countries, and companies
– Details of major planned Sterile Injectables projects in the world up to 2026
Also you can request us for sample in pdf with more details and graph: https://www.credenceresearch.com/sample-request/57842
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Credence Research Inc.
105 N 1st ST #429
Toll Free (US/CANADA): +1-800-361-8290